BackDiaMedica Therapeutics Overview

DiaMedica Therapeutics Common Stock

Latest common stock for DMAC: $0.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$0.00

Peer average

Loading

DiaMedica Therapeutics Common Stock History

Loading

DiaMedica Therapeutics vs. peers: Common Stock Comparison

Loading

DiaMedica Therapeutics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

DiaMedica Therapeutics (DMAC) FAQ

As of the most recent data (March 2026), DMAC shows a common stock of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMAC's common stock is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether DiaMedica Therapeutics is outperforming or lagging.

Tracking DMAC's common stock over time shows whether DiaMedica Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has DiaMedica Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $0) with ownership activity and broader fundamentals.

DiaMedica Therapeutics's common stock is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.